Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain

Romero Gómez, Manuel 1967-Kachru, NanditaAscanio, MeritxellDarbà, JosepShreay, Sanatan2021-03-192021-03-192020-12-110025-7974https://hdl.handle.net/2445/175433The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) presents many public health challenges, including a substantial impact on healthcare resource utilization and costs. There are important regional differences in the burden of NAFLD/NASH, and Spain-specific data are lacking. This retrospective, observational study examined the impact of liver disease severity, comorbidities, and demographics on healthcare resource utilization and costs in Spain (...)application/pdfengcc-by (c) Romero Gómez, Manuel 1967- et al., 2020http://creativecommons.org/licenses/by/3.0/esCost de l'assistència sanitàriaGestió hospitalàriaHepatitisMalalties del fetgeCost of medical careHospital administrationHepatitisLiver diseasesDisease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spaininfo:eu-repo/semantics/article7052742021-03-19info:eu-repo/semantics/openAccess